161 related articles for article (PubMed ID: 32545483)
1. Silencing Core Spliceosome Sm Gene Expression Induces a Cytotoxic Splicing Switch in the Proteasome Subunit Beta 3 mRNA in Non-Small Cell Lung Cancer Cells.
Blijlevens M; Komor MA; Sciarrillo R; Smit EF; Fijneman RJA; van Beusechem VW
Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32545483
[TBL] [Abstract][Full Text] [Related]
2. A genome-wide siRNA screen for regulators of tumor suppressor p53 activity in human non-small cell lung cancer cells identifies components of the RNA splicing machinery as targets for anticancer treatment.
Siebring-van Olst E; Blijlevens M; de Menezes RX; van der Meulen-Muileman IH; Smit EF; van Beusechem VW
Mol Oncol; 2017 May; 11(5):534-551. PubMed ID: 28296343
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of SF3B1 by molecules targeting the spliceosome results in massive aberrant exon skipping.
Wu G; Fan L; Edmonson MN; Shaw T; Boggs K; Easton J; Rusch MC; Webb TR; Zhang J; Potter PM
RNA; 2018 Aug; 24(8):1056-1066. PubMed ID: 29844105
[TBL] [Abstract][Full Text] [Related]
4. High-throughput RNAi screening reveals cancer-selective lethal targets in the RNA spliceosome.
Blijlevens M; van der Meulen-Muileman IH; de Menezes RX; Smit EF; van Beusechem VW
Oncogene; 2019 May; 38(21):4142-4153. PubMed ID: 30705407
[TBL] [Abstract][Full Text] [Related]
5. Aberrant splicing isoforms detected by full-length transcriptome sequencing as transcripts of potential neoantigens in non-small cell lung cancer.
Oka M; Xu L; Suzuki T; Yoshikawa T; Sakamoto H; Uemura H; Yoshizawa AC; Suzuki Y; Nakatsura T; Ishihama Y; Suzuki A; Seki M
Genome Biol; 2021 Jan; 22(1):9. PubMed ID: 33397462
[TBL] [Abstract][Full Text] [Related]
6. Identification of proteasomal catalytic subunit PSMA6 as a therapeutic target for lung cancer.
Kakumu T; Sato M; Goto D; Kato T; Yogo N; Hase T; Morise M; Fukui T; Yokoi K; Sekido Y; Girard L; Minna JD; Byers LA; Heymach JV; Coombes KR; Kondo M; Hasegawa Y
Cancer Sci; 2017 Apr; 108(4):732-743. PubMed ID: 28165654
[TBL] [Abstract][Full Text] [Related]
7. Titration of SF3B1 Activity Reveals Distinct Effects on the Transcriptome and Cell Physiology.
Kim Guisbert KS; Mossiah I; Guisbert E
Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33348896
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of Splicing Factor 3b Subunit 1 (SF3B1) Reduced Cell Proliferation, Induced Apoptosis and Resulted in Cell Cycle Arrest by Regulating Homeobox A10 (HOXA10) Splicing in AGS and MKN28 Human Gastric Cancer Cells.
Zhang Y; Yuan Z; Jiang Y; Shen R; Gu M; Xu W; Gu X
Med Sci Monit; 2020 Jan; 26():e919460. PubMed ID: 31927557
[TBL] [Abstract][Full Text] [Related]
9. Knockdown of SF3B1 inhibits cell proliferation, invasion and migration triggering apoptosis in breast cancer via aberrant splicing.
Zhang L; Zhang X; Zhang H; Liu F; Bi Y; Zhang Y; Cheng C; Liu J
Breast Cancer; 2020 May; 27(3):464-476. PubMed ID: 31919642
[TBL] [Abstract][Full Text] [Related]
10. SNRPB promotes the tumorigenic potential of NSCLC in part by regulating RAB26.
Liu N; Wu Z; Chen A; Wang Y; Cai D; Zheng J; Liu Y; Zhang L
Cell Death Dis; 2019 Sep; 10(9):667. PubMed ID: 31511502
[TBL] [Abstract][Full Text] [Related]
11. The splicing factor SNRPB promotes ovarian cancer progression through regulating aberrant exon skipping of POLA1 and BRCA2.
Li Y; Chen Z; Peng J; Yuan C; Yan S; Yang N; Li P; Kong B
Oncogene; 2023 Jul; 42(31):2386-2401. PubMed ID: 37391593
[TBL] [Abstract][Full Text] [Related]
12. Melanoma Differentiation-associated Gene 7/IL-24 Exerts Cytotoxic Effects by Altering the Alternative Splicing of Bcl-x Pre-mRNA via the SRC/PKCδ Signaling Axis.
Shapiro BA; Vu NT; Shultz MD; Shultz JC; Mietla JA; Gouda MM; Yacoub A; Dent P; Fisher PB; Park MA; Chalfant CE
J Biol Chem; 2016 Oct; 291(41):21669-21681. PubMed ID: 27519412
[TBL] [Abstract][Full Text] [Related]
13. Microprocessor-dependent processing of splice site overlapping microRNA exons does not result in changes in alternative splicing.
Pianigiani G; Licastro D; Fortugno P; Castiglia D; Petrovic I; Pagani F
RNA; 2018 Sep; 24(9):1158-1171. PubMed ID: 29895677
[TBL] [Abstract][Full Text] [Related]
14. Different splicing isoforms of ERCC1 affect the expression of its overlapping genes CD3EAP and PPP1R13L, and indicate a potential application in non-small cell lung cancer treatment.
Zhang G; Xue P; Cui S; Yu T; Xiao M; Zhang Q; Cai Y; Jin C; Yang J; Wu S; Lu X
Int J Oncol; 2018 Jun; 52(6):2155-2165. PubMed ID: 29620255
[TBL] [Abstract][Full Text] [Related]
15. Splicing factor SF3B1 promotes endometrial cancer progression via regulating KSR2 RNA maturation.
Popli P; Richters MM; Chadchan SB; Kim TH; Tycksen E; Griffith O; Thaker PH; Griffith M; Kommagani R
Cell Death Dis; 2020 Oct; 11(10):842. PubMed ID: 33040078
[TBL] [Abstract][Full Text] [Related]
16. Transcriptomic Characterization of SF3B1 Mutation Reveals Its Pleiotropic Effects in Chronic Lymphocytic Leukemia.
Wang L; Brooks AN; Fan J; Wan Y; Gambe R; Li S; Hergert S; Yin S; Freeman SS; Levin JZ; Fan L; Seiler M; Buonamici S; Smith PG; Chau KF; Cibulskis CL; Zhang W; Rassenti LZ; Ghia EM; Kipps TJ; Fernandes S; Bloch DB; Kotliar D; Landau DA; Shukla SA; Aster JC; Reed R; DeLuca DS; Brown JR; Neuberg D; Getz G; Livak KJ; Meyerson MM; Kharchenko PV; Wu CJ
Cancer Cell; 2016 Nov; 30(5):750-763. PubMed ID: 27818134
[TBL] [Abstract][Full Text] [Related]
17. Splicing modulation as novel therapeutic strategy against diffuse malignant peritoneal mesothelioma.
Sciarrillo R; Wojtuszkiewicz A; El Hassouni B; Funel N; Gandellini P; Lagerweij T; Buonamici S; Blijlevens M; Zeeuw van der Laan EA; Zaffaroni N; Deraco M; Kusamura S; Würdinger T; Peters GJ; Molthoff CFM; Jansen G; Kaspers GJL; Cloos J; Giovannetti E
EBioMedicine; 2019 Jan; 39():215-225. PubMed ID: 30581150
[TBL] [Abstract][Full Text] [Related]
18. Characterization of the aberrant splicing of DVL2 induced by cancer-associated SF3B1 mutation.
Zhao B; Hu X; Zhou Y; Shi Y; Qian R; Wan Y
Biochem Biophys Res Commun; 2021 Mar; 546():21-28. PubMed ID: 33561744
[TBL] [Abstract][Full Text] [Related]
19. CD44 splicing pattern is associated with disease progression in pulmonary adenocarcinoma.
Lee LN; Kuo SH; Lee YC; Chang YL; Chang HC; Jan IS; Yang PC
J Formos Med Assoc; 2005 Aug; 104(8):541-8. PubMed ID: 16193174
[TBL] [Abstract][Full Text] [Related]
20. Identification of alternative splicing events regulated by the oncogenic factor SRSF1 in lung cancer.
de Miguel FJ; Sharma RD; Pajares MJ; Montuenga LM; Rubio A; Pio R
Cancer Res; 2014 Feb; 74(4):1105-15. PubMed ID: 24371231
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
